Last quarter (Q4 2023), PDS Biotechnology's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, PDS Biotechnology's net income was $-10.90M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 43.05M	$ 43.05M	$ 41.67M	$ -21.44M	$ 14.90M	$ 17.08M
Operating Income	$ -43.05M	$ -43.05M	$ -41.67M	$ -21.44M	$ -14.90M	$ -17.08M
Net Non Operating Interest Income Expense	$ -1.30M	$ -1.30M	$ -381.34K	$ 4.35K	$ 55.01K	$ 319.93K
Other Income Expense	-	-	-	-	-	$ 9.38M
Pretax Income	$ -44.35M	$ -44.35M	$ -42.05M	$ -21.43M	$ -14.85M	$ -7.38M
Tax Provision	$ -1.40M	$ -1.40M	$ -1.20M	$ -4.50M	$ 0.00	$ -381.51K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -42.94M	$ -42.94M	$ -40.85M	$ -16.93M	$ -14.85M	$ -7.00M
Basic EPS	$ -1.38	$ -1.39	$ -1.43	$ -0.66	$ -0.89	$ -1.44
Diluted EPS	$ -1.38	$ -1.39	$ -1.43	$ -0.66	$ -0.89	$ -1.44
Basic Average Shares	$ 123.81M	$ 30.95M	$ 28.60M	$ 25.60M	$ 16.75M	$ 4.87M
Diluted Average Shares	$ 123.81M	$ 30.95M	$ 28.60M	$ 25.60M	$ 16.75M	$ 4.87M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 43.05M	$ 43.05M	$ 41.67M	$ -21.44M	$ 14.90M	$ 17.08M
Net Income From Continuing And Discontinued Operation	$ -42.94M	$ -42.94M	$ -40.85M	$ -16.93M	$ -14.85M	$ -7.00M
Normalized Income	$ -31.53M	$ -45.75M	$ -43.25M	-	$ -14.85M	$ -15.89M
Interest Expense	-	-	-	-	$ 0.00	$ 33.56K
EBIT	$ -40.14M	$ -40.14M	$ -40.74M	$ -21.43M	$ -14.90M	$ -7.35M
EBITDA	$ -39.27M	$ -39.27M	$ -40.26M	$ -21.19M	$ -14.89M	$ -7.25M

Currency in USD

PDS Biotechnology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing